 | • レポートコード：MRC2-11QY12280 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は高フェニルアラニン血症（HPA）のグローバル市場について調査・分析したレポートです。種類別（医薬品、サプリメント）市場規模、用途別（家庭、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別高フェニルアラニン血症（HPA）の競争状況、市場シェア ・世界の高フェニルアラニン血症（HPA）市場：種類別市場規模 2015年-2020年（医薬品、サプリメント） ・世界の高フェニルアラニン血症（HPA）市場：種類別市場規模予測 2021年-2026年（医薬品、サプリメント） ・世界の高フェニルアラニン血症（HPA）市場：用途別市場規模 2015年-2020年（家庭、病院） ・世界の高フェニルアラニン血症（HPA）市場：用途別市場規模予測 2021年-2026年（家庭、病院） ・北米の高フェニルアラニン血症（HPA）市場分析：米国、カナダ ・ヨーロッパの高フェニルアラニン血症（HPA）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの高フェニルアラニン血症（HPA）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の高フェニルアラニン血症（HPA）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの高フェニルアラニン血症（HPA）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Biomarin、Vitaflo、Mead Johnson、Nutricia、Abbott、Dr. Schar、Prominmetabolics、Cambrooke、Juvela、Firstplay Dietary ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Hyperphenylalaninemia (HPA) Market
The global Hyperphenylalaninemia (HPA) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hyperphenylalaninemia (HPA) Scope and Market Size
Hyperphenylalaninemia (HPA) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hyperphenylalaninemia (HPA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Biomarin
Vitaflo
Mead Johnson
Nutricia
Abbott
Dr. Schar
Prominmetabolics
Cambrooke
Juvela
Firstplay Dietary
Market segment by Type, the product can be split into
Medications
Supplements
Market segment by Application, split into
Household
Hospital
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hyperphenylalaninemia (HPA) Revenue
1.4 Market by Type
1.4.1 Global Hyperphenylalaninemia (HPA) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medications
1.4.3 Supplements
1.5 Market by Application
1.5.1 Global Hyperphenylalaninemia (HPA) Market Share by Application: 2020 VS 2026
1.5.2 Household
1.5.3 Hospital
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hyperphenylalaninemia (HPA) Market Perspective (2015-2026)
2.2 Global Hyperphenylalaninemia (HPA) Growth Trends by Regions
2.2.1 Hyperphenylalaninemia (HPA) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hyperphenylalaninemia (HPA) Historic Market Share by Regions (2015-2020)
2.2.3 Hyperphenylalaninemia (HPA) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hyperphenylalaninemia (HPA) Market Growth Strategy
2.3.6 Primary Interviews with Key Hyperphenylalaninemia (HPA) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hyperphenylalaninemia (HPA) Players by Market Size
3.1.1 Global Top Hyperphenylalaninemia (HPA) Players by Revenue (2015-2020)
3.1.2 Global Hyperphenylalaninemia (HPA) Revenue Market Share by Players (2015-2020)
3.1.3 Global Hyperphenylalaninemia (HPA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hyperphenylalaninemia (HPA) Market Concentration Ratio
3.2.1 Global Hyperphenylalaninemia (HPA) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hyperphenylalaninemia (HPA) Revenue in 2019
3.3 Hyperphenylalaninemia (HPA) Key Players Head office and Area Served
3.4 Key Players Hyperphenylalaninemia (HPA) Product Solution and Service
3.5 Date of Enter into Hyperphenylalaninemia (HPA) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hyperphenylalaninemia (HPA) Historic Market Size by Type (2015-2020)
4.2 Global Hyperphenylalaninemia (HPA) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020)
5.2 Global Hyperphenylalaninemia (HPA) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hyperphenylalaninemia (HPA) Market Size (2015-2020)
6.2 Hyperphenylalaninemia (HPA) Key Players in North America (2019-2020)
6.3 North America Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020)
6.4 North America Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hyperphenylalaninemia (HPA) Market Size (2015-2020)
7.2 Hyperphenylalaninemia (HPA) Key Players in Europe (2019-2020)
7.3 Europe Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020)
7.4 Europe Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020)
8 China
8.1 China Hyperphenylalaninemia (HPA) Market Size (2015-2020)
8.2 Hyperphenylalaninemia (HPA) Key Players in China (2019-2020)
8.3 China Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020)
8.4 China Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hyperphenylalaninemia (HPA) Market Size (2015-2020)
9.2 Hyperphenylalaninemia (HPA) Key Players in Japan (2019-2020)
9.3 Japan Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020)
9.4 Japan Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hyperphenylalaninemia (HPA) Market Size (2015-2020)
10.2 Hyperphenylalaninemia (HPA) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020)
10.4 Southeast Asia Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020)
11 India
11.1 India Hyperphenylalaninemia (HPA) Market Size (2015-2020)
11.2 Hyperphenylalaninemia (HPA) Key Players in India (2019-2020)
11.3 India Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020)
11.4 India Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hyperphenylalaninemia (HPA) Market Size (2015-2020)
12.2 Hyperphenylalaninemia (HPA) Key Players in Central & South America (2019-2020)
12.3 Central & South America Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020)
12.4 Central & South America Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Biomarin
13.1.1 Biomarin Company Details
13.1.2 Biomarin Business Overview
13.1.3 Biomarin Hyperphenylalaninemia (HPA) Introduction
13.1.4 Biomarin Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020))
13.1.5 Biomarin Recent Development
13.2 Vitaflo
13.2.1 Vitaflo Company Details
13.2.2 Vitaflo Business Overview
13.2.3 Vitaflo Hyperphenylalaninemia (HPA) Introduction
13.2.4 Vitaflo Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020)
13.2.5 Vitaflo Recent Development
13.3 Mead Johnson
13.3.1 Mead Johnson Company Details
13.3.2 Mead Johnson Business Overview
13.3.3 Mead Johnson Hyperphenylalaninemia (HPA) Introduction
13.3.4 Mead Johnson Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020)
13.3.5 Mead Johnson Recent Development
13.4 Nutricia
13.4.1 Nutricia Company Details
13.4.2 Nutricia Business Overview
13.4.3 Nutricia Hyperphenylalaninemia (HPA) Introduction
13.4.4 Nutricia Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020)
13.4.5 Nutricia Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview
13.5.3 Abbott Hyperphenylalaninemia (HPA) Introduction
13.5.4 Abbott Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 Dr. Schar
13.6.1 Dr. Schar Company Details
13.6.2 Dr. Schar Business Overview
13.6.3 Dr. Schar Hyperphenylalaninemia (HPA) Introduction
13.6.4 Dr. Schar Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020)
13.6.5 Dr. Schar Recent Development
13.7 Prominmetabolics
13.7.1 Prominmetabolics Company Details
13.7.2 Prominmetabolics Business Overview
13.7.3 Prominmetabolics Hyperphenylalaninemia (HPA) Introduction
13.7.4 Prominmetabolics Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020)
13.7.5 Prominmetabolics Recent Development
13.8 Cambrooke
13.8.1 Cambrooke Company Details
13.8.2 Cambrooke Business Overview
13.8.3 Cambrooke Hyperphenylalaninemia (HPA) Introduction
13.8.4 Cambrooke Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020)
13.8.5 Cambrooke Recent Development
13.9 Juvela
13.9.1 Juvela Company Details
13.9.2 Juvela Business Overview
13.9.3 Juvela Hyperphenylalaninemia (HPA) Introduction
13.9.4 Juvela Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020)
13.9.5 Juvela Recent Development
13.10 Firstplay Dietary
13.10.1 Firstplay Dietary Company Details
13.10.2 Firstplay Dietary Business Overview
13.10.3 Firstplay Dietary Hyperphenylalaninemia (HPA) Introduction
13.10.4 Firstplay Dietary Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020)
13.10.5 Firstplay Dietary Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hyperphenylalaninemia (HPA) Key Market Segments
Table 2. Key Players Covered: Ranking by Hyperphenylalaninemia (HPA) Revenue
Table 3. Ranking of Global Top Hyperphenylalaninemia (HPA) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hyperphenylalaninemia (HPA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medications
Table 6. Key Players of Supplements
Table 7. Global Hyperphenylalaninemia (HPA) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hyperphenylalaninemia (HPA) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hyperphenylalaninemia (HPA) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hyperphenylalaninemia (HPA) Market Share by Regions (2015-2020)
Table 11. Global Hyperphenylalaninemia (HPA) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hyperphenylalaninemia (HPA) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hyperphenylalaninemia (HPA) Market Growth Strategy
Table 17. Main Points Interviewed from Key Hyperphenylalaninemia (HPA) Players
Table 18. Global Hyperphenylalaninemia (HPA) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hyperphenylalaninemia (HPA) Market Share by Players (2015-2020)
Table 20. Global Top Hyperphenylalaninemia (HPA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperphenylalaninemia (HPA) as of 2019)
Table 21. Global Hyperphenylalaninemia (HPA) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hyperphenylalaninemia (HPA) Product Solution and Service
Table 24. Date of Enter into Hyperphenylalaninemia (HPA) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hyperphenylalaninemia (HPA) Market Size Share by Type (2015-2020)
Table 28. Global Hyperphenylalaninemia (HPA) Revenue Market Share by Type (2021-2026)
Table 29. Global Hyperphenylalaninemia (HPA) Market Size Share by Application (2015-2020)
Table 30. Global Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hyperphenylalaninemia (HPA) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hyperphenylalaninemia (HPA) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hyperphenylalaninemia (HPA) Market Share (2019-2020)
Table 34. North America Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hyperphenylalaninemia (HPA) Market Share by Type (2015-2020)
Table 36. North America Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hyperphenylalaninemia (HPA) Market Share by Application (2015-2020)
Table 38. Europe Key Players Hyperphenylalaninemia (HPA) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hyperphenylalaninemia (HPA) Market Share (2019-2020)
Table 40. Europe Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hyperphenylalaninemia (HPA) Market Share by Type (2015-2020)
Table 42. Europe Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hyperphenylalaninemia (HPA) Market Share by Application (2015-2020)
Table 44. China Key Players Hyperphenylalaninemia (HPA) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hyperphenylalaninemia (HPA) Market Share (2019-2020)
Table 46. China Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020) (Million US$)
Table 47. China Hyperphenylalaninemia (HPA) Market Share by Type (2015-2020)
Table 48. China Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020) (Million US$)
Table 49. China Hyperphenylalaninemia (HPA) Market Share by Application (2015-2020)
Table 50. Japan Key Players Hyperphenylalaninemia (HPA) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hyperphenylalaninemia (HPA) Market Share (2019-2020)
Table 52. Japan Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hyperphenylalaninemia (HPA) Market Share by Type (2015-2020)
Table 54. Japan Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hyperphenylalaninemia (HPA) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hyperphenylalaninemia (HPA) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hyperphenylalaninemia (HPA) Market Share (2019-2020)
Table 58. Southeast Asia Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hyperphenylalaninemia (HPA) Market Share by Type (2015-2020)
Table 60. Southeast Asia Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hyperphenylalaninemia (HPA) Market Share by Application (2015-2020)
Table 62. India Key Players Hyperphenylalaninemia (HPA) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hyperphenylalaninemia (HPA) Market Share (2019-2020)
Table 64. India Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020) (Million US$)
Table 65. India Hyperphenylalaninemia (HPA) Market Share by Type (2015-2020)
Table 66. India Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020) (Million US$)
Table 67. India Hyperphenylalaninemia (HPA) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hyperphenylalaninemia (HPA) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hyperphenylalaninemia (HPA) Market Share (2019-2020)
Table 70. Central & South America Hyperphenylalaninemia (HPA) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hyperphenylalaninemia (HPA) Market Share by Type (2015-2020)
Table 72. Central & South America Hyperphenylalaninemia (HPA) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hyperphenylalaninemia (HPA) Market Share by Application (2015-2020)
Table 74. Biomarin Company Details
Table 75. Biomarin Business Overview
Table 76. Biomarin Product
Table 77. Biomarin Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020) (Million US$)
Table 78. Biomarin Recent Development
Table 79. Vitaflo Company Details
Table 80. Vitaflo Business Overview
Table 81. Vitaflo Product
Table 82. Vitaflo Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020) (Million US$)
Table 83. Vitaflo Recent Development
Table 84. Mead Johnson Company Details
Table 85. Mead Johnson Business Overview
Table 86. Mead Johnson Product
Table 87. Mead Johnson Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020) (Million US$)
Table 88. Mead Johnson Recent Development
Table 89. Nutricia Company Details
Table 90. Nutricia Business Overview
Table 91. Nutricia Product
Table 92. Nutricia Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020) (Million US$)
Table 93. Nutricia Recent Development
Table 94. Abbott Company Details
Table 95. Abbott Business Overview
Table 96. Abbott Product
Table 97. Abbott Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020) (Million US$)
Table 98. Abbott Recent Development
Table 99. Dr. Schar Company Details
Table 100. Dr. Schar Business Overview
Table 101. Dr. Schar Product
Table 102. Dr. Schar Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020) (Million US$)
Table 103. Dr. Schar Recent Development
Table 104. Prominmetabolics Company Details
Table 105. Prominmetabolics Business Overview
Table 106. Prominmetabolics Product
Table 107. Prominmetabolics Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020) (Million US$)
Table 108. Prominmetabolics Recent Development
Table 109. Cambrooke Business Overview
Table 110. Cambrooke Product
Table 111. Cambrooke Company Details
Table 112. Cambrooke Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020) (Million US$)
Table 113. Cambrooke Recent Development
Table 114. Juvela Company Details
Table 115. Juvela Business Overview
Table 116. Juvela Product
Table 117. Juvela Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020) (Million US$)
Table 118. Juvela Recent Development
Table 119. Firstplay Dietary Company Details
Table 120. Firstplay Dietary Business Overview
Table 121. Firstplay Dietary Product
Table 122. Firstplay Dietary Revenue in Hyperphenylalaninemia (HPA) Business (2015-2020) (Million US$)
Table 123. Firstplay Dietary Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hyperphenylalaninemia (HPA) Market Share by Type: 2020 VS 2026
Figure 2. Medications Features
Figure 3. Supplements Features
Figure 4. Global Hyperphenylalaninemia (HPA) Market Share by Application: 2020 VS 2026
Figure 5. Household Case Studies
Figure 6. Hospital Case Studies
Figure 7. Hyperphenylalaninemia (HPA) Report Years Considered
Figure 8. Global Hyperphenylalaninemia (HPA) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Hyperphenylalaninemia (HPA) Market Share by Regions: 2020 VS 2026
Figure 10. Global Hyperphenylalaninemia (HPA) Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Hyperphenylalaninemia (HPA) Market Share by Players in 2019
Figure 13. Global Top Hyperphenylalaninemia (HPA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperphenylalaninemia (HPA) as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Hyperphenylalaninemia (HPA) Revenue in 2019
Figure 15. North America Hyperphenylalaninemia (HPA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Hyperphenylalaninemia (HPA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Hyperphenylalaninemia (HPA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Hyperphenylalaninemia (HPA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Hyperphenylalaninemia (HPA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Hyperphenylalaninemia (HPA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Hyperphenylalaninemia (HPA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
長時間作用型注射剤（LAI）の世界市場（～2026年） Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdo…- ビタミンサプリメントの世界市場（～2026年） Vitamin is a kind of microorganic substance which must be obtained from food in order to maintain normal physiological function of human and animals. It plays an important role in human growth, metabolism and development. The increase in awareness among people related to the vitamin supplements, has…
- 動物用風味付医薬品の世界市場（～2026年） Flavored Veterinary Medications are the medicines available in different flavors for the diagnosis, treatment and prevention of diseases in animals or birds. Technological advancement, innovation, increasing demand of flavored medications by pet owners, increasing pet health awareness, less expensiv…
- 免疫システムサプリメントの世界市場（～2026年） Market Analysis and Insights: Global Immune System Supplements Market The global Immune System Supplements market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…
- 嚥下障害サプリメントの世界市場（～2026年） According to statistics compiled by the CDC, almost 800,000 people are afflicted by strokes every year in the U.S. alone and nearly half of them have some sort of swallowing disorders. In addition, the National Foundation of Swallowing Disorders estimates that 22% of the American geriatric populatio…